Q2 2026 Holdings
Filed 2026-08-13 | 29 holdings | $191.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Plains GP Holdings LP-Cl(PAGPEUR) | COMM | 72651A207 | $30.9M | 1,272,360 | 16.2% |
| Achieve Life Sciences Inc(ACHV) | COMM | 004468500 | $26.3M | 4,034,018 | 13.8% |
| Corcept Therapeutics Inc(CORT) | COMM | 218352102 | $11.9M | 136,499 | 6.2% |
| Phathom Pharmaceuticals I(PHAT) | COMM | 71722W107 | $11.4M | 1,050,358 | 6.0% |
| Delcath Systems Inc(DCTH) | COMM | 24661P807 | $11.0M | 871,460 | 5.7% |
| Milestone Pharmaceuticals(MIST) | COMM | 59935V107 | $10.0M | 7,429,590 | 5.2% |
| Compass Pathways PLC(CMPS) | ADRS | 20451W101 | $8.1M | 573,086 | 4.2% |
| Kyverna Therapeutics Inc(KYTX) | COMM | 501976104 | $7.9M | 883,198 | 4.1% |
| Artiva Biotherapeutics in(ARTV) | COMM | 04317A107 | $6.8M | 696,436 | 3.5% |
| Abeona Therapeutics Inc(ABEO) | COMM | 00289Y206 | $6.1M | 983,070 | 3.2% |
| Aquestive Therapeutics in(AQST) | COMM | 03843E104 | $6.0M | 1,442,397 | 3.1% |
| Palisade BIO Inc(PALI) | COMM | 696389402 | $5.4M | 2,582,388 | 2.8% |
| Immunic Inc(IMUX) | COMM | 4525EP200 | $5.0M | 325,022 | 2.6% |
| Inventiva SA(IVA) | COMM | 46124U107 | $4.8M | 1,281,212 | 2.5% |
| SAB Biotherapeutics Inc(SABS) | COMM | 78397T202 | $4.2M | 1,076,578 | 2.2% |
| Orchestra Biomed Holdings(OBIO) | COMM | 68572M106 | $3.9M | 896,701 | 2.0% |
| Celldex Therapeutics Inc(CLDX) | COMM | 15117B202 | $3.9M | 103,695 | 2.0% |
| Zevra Therapeutics Inc(ZVRA) | COMM | 488445206 | $3.6M | 253,544 | 1.9% |
| Ocular Therapeutix Inc(OCUL) | COMM | 67576A100 | $3.5M | 357,966 | 1.8% |
| 4D Molecular Therapeutics in(FDMT) | COMM | 35104E100 | $3.4M | 252,654 | 1.8% |
| Ovid Therapeutics Inc(OVID) | COMM | 690469101 | $3.0M | 1,115,538 | 1.6% |
| Eyepoint Inc(EYPT) | COMM | 30233G209 | $2.7M | 191,745 | 1.4% |
| Upstream BIO Inc(UPB) | COMM | 91678A107 | $2.4M | 350,389 | 1.3% |
| Scynexis Inc(SCYX) | COMM | 811292309 | $2.2M | 543,478 | 1.2% |
| Silence Therapeutics PLC(SLN) | ADRS | 82686Q101 | $2.1M | 191,733 | 1.1% |
| Leonabio Inc(LONA) | COMM | 04746L203 | $1.4M | 149,279 | 0.7% |
| Maze Therapeutics Inc(MAZE) | COMM | 578784100 | $1.3M | 43,798 | 0.7% |
| Corvus Pharmaceuticals Inc(CRVS) | COMM | 221015100 | $1.1M | 70,380 | 0.6% |
| Sagimet Biosciences Inc(SGMT) | COMM | 786700104 | $973.0K | 125,878 | 0.5% |